We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.52B
AUM Growth
-$173M
Cap. Flow
-$49.9M
Cap. Flow %
-1.98%
Top 10 Hldgs %
37.25%
Holding
3,473
New
219
Increased
908
Reduced
1,468
Closed
292

Sector Composition

Rank Sector Weight
1 Technology 15.38%
2 Financials 8.17%
3 Healthcare 7.07%
4 Consumer Discretionary 4.99%
5 Communication Services 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVE icon
76
iShares S&P 500 Value ETF
IVE
$49.8B
$5.34M 0.21%
33,809
+1,238
+4% +$191K
CSCO icon
77
Cisco
CSCO
$479B
$5.31M 0.21%
94,797
-1,763
-2% -$99.8K
VYM icon
78
Vanguard High Dividend Yield ETF
VYM
$82.8B
$5.2M 0.21%
45,687
+333
+0.7% +$37.1K
CRWD icon
79
CrowdStrike
CRWD
$218B
$5.2M 0.21%
92,444
-2,296
-2% -$107K
ABBV icon
80
AbbVie
ABBV
$435B
$5.12M 0.2%
31,280
-322
-1% -$46.8K
VWO icon
81
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$4.84M 0.19%
103,171
-26,093
-20% -$1.26M
BOND icon
82
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.47B
$4.76M 0.19%
46,702
+9
+0% +$947
GOVT icon
83
iShares US Treasury Bond ETF
GOVT
$43.6B
$4.74M 0.19%
190,136
-80,357
-30% -$2.06M
SCHB icon
84
Schwab US Broad Market ETF
SCHB
$44.9B
$4.72M 0.19%
261,426
-25,800
-9% -$453K
NARI
85
DELISTED
Inari Medical, Inc. Common Stock
NARI
$4.57M 0.18%
50,380
+28
+0.1% +$2.29K
DIS icon
86
Walt Disney
DIS
$181B
$4.54M 0.18%
32,225
+879
+3% +$127K
VEA icon
87
Vanguard FTSE Developed Markets ETF
VEA
$236B
$4.46M 0.18%
91,500
-91,233
-50% -$4.44M
COMP icon
88
Compass
COMP
$9.66B
$4.43M 0.18%
557,030
ILMN icon
89
Illumina
ILMN
$28.4B
$4.42M 0.18%
12,921
-2,956
-19% -$998K
PYPL icon
90
PayPal
PYPL
$50.5B
$4.34M 0.17%
36,633
-5,484
-13% -$730K
ACN icon
91
Accenture
ACN
$108B
$4.34M 0.17%
12,820
-1,455
-10% -$491K
XOM icon
92
ExxonMobil
XOM
$634B
$4.32M 0.17%
51,505
+1,979
+4% +$154K
BMY icon
93
Bristol-Myers Squibb
BMY
$132B
$4.23M 0.17%
57,410
+9,942
+21% +$668K
PANW icon
94
Palo Alto Networks
PANW
$297B
$4.23M 0.17%
41,190
+20,424
+98% +$1.83M
BAC icon
95
Bank of America
BAC
$442B
$4.22M 0.17%
98,115
-2,873
-3% -$130K
IJS icon
96
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
$4.21M 0.17%
40,756
+553
+1% +$56.4K
TXN icon
97
Texas Instruments
TXN
$261B
$4.2M 0.17%
22,403
+5,166
+30% +$911K
PEP icon
98
PepsiCo
PEP
$190B
$4.16M 0.17%
24,772
-263
-1% -$44.2K
NKE icon
99
Nike
NKE
$61.9B
$4.07M 0.16%
29,407
-3,887
-12% -$546K
VGT icon
100
Vanguard Information Technology ETF
VGT
$149B
$4.05M 0.16%
76,784
+2,880
+4% +$148K

Similar funds

Parallel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q1 2022 filing shows 219 new, 908 increased, 1,468 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
  • Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
  • Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
  • Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
  • Parallel Advisors opened 219 new positions and closed 292 in Q1 2022.
  • Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.